These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 37895938)

  • 1. Bacteriophages and Their Host Range in Multidrug-Resistant Bacterial Disease Treatment.
    Chung KM; Liau XL; Tang SS
    Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutant and Recombinant Phages Selected from
    Peters TL; Song Y; Bryan DW; Hudson LK; Denes TG
    Appl Environ Microbiol; 2020 Oct; 86(22):. PubMed ID: 32887717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriophage Effectively Rescues Pneumonia Caused by Prevalent Multidrug-Resistant
    Gan L; Fu H; Tian Z; Cui J; Yan C; Xue G; Fan Z; Du B; Feng J; Zhao H; Feng Y; Xu Z; Fu T; Cui X; Zhang R; Du S; Liu S; Zhou Y; Zhang Q; Cao L; Yuan J
    Microbiol Spectr; 2022 Oct; 10(5):e0235822. PubMed ID: 36165773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges and Promises for Planning Future Clinical Research Into Bacteriophage Therapy Against
    Rossitto M; Fiscarelli EV; Rosati P
    Front Microbiol; 2018; 9():775. PubMed ID: 29780361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Phage Therapy Need a Pan-Phage?
    Bozidis P; Markou E; Gouni A; Gartzonika K
    Pathogens; 2024 Jun; 13(6):. PubMed ID: 38921819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phage and phage cocktails formulations.
    Mani I
    Prog Mol Biol Transl Sci; 2023; 200():159-169. PubMed ID: 37739554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteriophage genome engineering for phage therapy to combat bacterial antimicrobial resistance as an alternative to antibiotics.
    Usman SS; Uba AI; Christina E
    Mol Biol Rep; 2023 Aug; 50(8):7055-7067. PubMed ID: 37392288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteriophage isolated from non-target bacteria demonstrates broad host range infectivity against multidrug-resistant bacteria.
    Ngiam L; Schembri MA; Weynberg K; Guo J
    Environ Microbiol; 2021 Sep; 23(9):5569-5586. PubMed ID: 34390602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancing phage therapy through the lens of virus host-breadth and emergence potential.
    Bono LM; Mao S; Done RE; Okamoto KW; Chan BK; Turner PE
    Adv Virus Res; 2021; 111():63-110. PubMed ID: 34663499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Safety of Bacteriophages in Treatment of Diseases Caused by Multidrug-Resistant Bacteria.
    Chung KM; Nang SC; Tang SS
    Pharmaceuticals (Basel); 2023 Sep; 16(10):. PubMed ID: 37895818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of Potential Phages against Multidrug-Resistant Bacterial Isolates: Promising Agents in the Rivers of Kathmandu, Nepal.
    Bhetwal A; Maharjan A; Shakya S; Satyal D; Ghimire S; Khanal PR; Parajuli NP
    Biomed Res Int; 2017; 2017():3723254. PubMed ID: 29359149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phage Engineering for Targeted Multidrug-Resistant
    Song J; Liu Z; Zhang Q; Liu Y; Chen Y
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Group of Promiscuous Podophages Infecting Diverse Gammaproteobacteria from River Communities Exhibits Dynamic Intergenus Host Adaptation.
    Cazares D; Cazares A; Figueroa W; Guarneros G; Edwards RA; Vinuesa P
    mSystems; 2021 Feb; 6(1):. PubMed ID: 33531404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More Is Better: Selecting for Broad Host Range Bacteriophages.
    Ross A; Ward S; Hyman P
    Front Microbiol; 2016; 7():1352. PubMed ID: 27660623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of 29 newly isolated bacteriophages as a potential therapeutic agent against IMP-6-producing
    Kondo K; Nakano S; Hisatsune J; Sugawara Y; Kataoka M; Kayama S; Sugai M; Kawano M
    Microbiol Spectr; 2023 Sep; 11(5):e0476122. PubMed ID: 37724861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How Phages Overcome the Challenges of Drug Resistant Bacteria in Clinical Infections.
    Taati Moghadam M; Amirmozafari N; Shariati A; Hallajzadeh M; Mirkalantari S; Khoshbayan A; Masjedian Jazi F
    Infect Drug Resist; 2020; 13():45-61. PubMed ID: 32021319
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Vaitekenas A; Tai AS; Ramsay JP; Stick SM; Kicic A
    Antibiotics (Basel); 2021 Feb; 10(2):. PubMed ID: 33540528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phage Cocktails Constrain the Growth of
    Wandro S; Ghatbale P; Attai H; Hendrickson C; Samillano C; Suh J; Dunham SJB; Pride DT; Whiteson K
    mSystems; 2022 Aug; 7(4):e0001922. PubMed ID: 35762793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phage-Derived Antibacterials: Harnessing the Simplicity, Plasticity, and Diversity of Phages.
    Kim BO; Kim ES; Yoo YJ; Bae HW; Chung IY; Cho YH
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30889807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phage Therapy Is Effective in a Mouse Model of Bacterial Equine Keratitis.
    Furusawa T; Iwano H; Hiyashimizu Y; Matsubara K; Higuchi H; Nagahata H; Niwa H; Katayama Y; Kinoshita Y; Hagiwara K; Iwasaki T; Tanji Y; Yokota H; Tamura Y
    Appl Environ Microbiol; 2016 Sep; 82(17):5332-9. PubMed ID: 27342558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.